Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, A.
Right arrow Articles by Oku, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, A.
Right arrow Articles by Oku, N.
[Cancer Research 61, 5065-5069, July 1, 2001]
© 2001 American Association for Cancer Research


Experimental Therapeutics

Zinc-65 Imaging of Rat Brain Tumors

Atsushi Takeda1, Haruna Tamano, Shuichi Enomoto and Naoto Oku

Department of Radiobiochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan [A. T., N. O.], and The Institute of Physical and Chemical Research (RIKEN), Wako, Saitama, 351-0198, Japan [H. T., S. E.]

The uptake of zinc, an essential nutrient, is critical for cell proliferation. On the basis of the idea that zinc uptake can be an index of viability in proliferating cells, tumor imaging with 65Zn was performed using autoradiography. After s.c. implantation of ascites hepatoma (AH7974F) cells into the dorsum, 1 h after i.v. injection of 65ZnCl2, 65Zn uptake in the tumor was higher than in the brain tissue but lower than in the liver, which suggests that brain tumors can be positively imaged with 65Zn. After implantation of AH7974F cells into the periaqueductal gray, 1 h after i.v. injection of 65ZnCl2, 65Zn uptake in the tumor was ~10 times higher than in other brain regions. After implantation of C6 glioma cells into the hippocampus, 65Zn uptake in the tumor was also much higher than in other brain regions. The present findings demonstrate that brain tumors can be imaged with radioactive zinc. To compare brain tumor imaging with 65Zn with that of [18F]fluorodeoxyglucose (FDG), which is widely used for the diagnosis of brain tumors, 14C-FDG imaging of the C6 glioma was performed in the same manner. 14C-FDG uptake in the tumor was ~1.5 times higher than in the contralateral region in which 14C-FDG uptake was relatively high. It is likely that zinc uptake is more specific for brain tumors than is FDG uptake, which suggests that there is great potential for the use of 69mZn, a short half-life {gamma} emitter, in the diagnosis of brain tumors.




This article has been cited by other articles:


Home page
JNMHome page
N. Spaeth, M. T. Wyss, B. Weber, S. Scheidegger, A. Lutz, J. Verwey, I. Radovanovic, J. Pahnke, D. Wild, G. Westera, et al.
Uptake of 18F-Fluorocholine, 18F-Fluoroethyl-L-Tyrosine, and 18F-FDG in Acute Cerebral Radiation Injury in the Rat: Implications for Separation of Radiation Necrosis from Tumor Recurrence
J. Nucl. Med., November 1, 2004; 45(11): 1931 - 1938.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.